Doxorubicin Completed Phase 2 Trials for Adenocarcinoma of GE Junction / Adenocarcinoma of Stomach / Adenocarcinoma Of Esophagus Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00165191Doxorubicin, Cisplatin, 5-Fluorouracil in Patients With Advanced Adenocarcinoma of the Stomach or Esophagus